Page last updated: 2024-10-27

fleroxacin and Obesity

fleroxacin has been researched along with Obesity in 1 studies

Fleroxacin: A broad-spectrum antimicrobial fluoroquinolone. The drug strongly inhibits the DNA-supercoiling activity of DNA GYRASE.
fleroxacin : A fluoroquinolone antibiotic that is 4-oxo-1,4-dihydroquinoline which is substituted at positions 1, 3, 6, 7 and 8 by 2-fluoroethyl, carboxy, fluoro, 4-methylpiperazin-1-yl and fluoro groups, respectively. It is active against many Gram-positive and Gram-negative bacteria.

Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).

Research Excerpts

ExcerptRelevanceReference
"This is the first study to show a positive association of enrofloxacin internal exposure with overweight or obesity risk in children, demonstrating that more attention should be given to the usage and disposal of fluoroquinolones to safeguard children's health."4.12Association between fluoroquinolone exposure and children's growth and development: A multisite biomonitoring-based study in northern China. ( Gao, M; Li, H; Li, W; Pan, X; Shan, L; Tian, H; Wang, J, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Shan, L1
Gao, M1
Pan, X1
Li, W1
Wang, J1
Li, H1
Tian, H1

Other Studies

1 other study available for fleroxacin and Obesity

ArticleYear
Association between fluoroquinolone exposure and children's growth and development: A multisite biomonitoring-based study in northern China.
    Environmental research, 2022, Volume: 214, Issue:Pt 2

    Topics: Animals; Anti-Bacterial Agents; Biological Monitoring; Child; China; Ciprofloxacin; Enrofloxacin; Fl

2022